Giulia Armaroli - I am a medical doctor and an academic researcher in paediatric Rheumatology at the St. Augustin Children's Hospital, Germany. Currently, I am finishing my speciality training in general paediatrics.
I undertook my M.D. at the University Alma Mater Studiorum of Bologna, Italy, from which I graduated in 2016 with a thesis on the role of S100 proteins as biomarker of disease activity in rare chronic paediatric vasculitides, including polyarteritis nodosa (PAN) and ANCA-associated vasculitides.
From 2014 to 2015 and again from 2016 to 2017, I was research fellow at the University of Muenster, Germany, where I mainly focused on the possible role of S100 proteins in the pathogenesis of coronaric vasculitic damage through pro-inflammatory endothelial activation in Kawasaki disease.
Since 2019, I am active in clinical research as investigator for several clinical trials conducted on children with juvenile idiopathic arthritis (JIA) by the paediatric Rheumatology Centre of the St. Augustin Children's Hospital, Germany. Driven by the life-changing effect of biologic agents on many young JIA patients observed in daily clinical care, I recently focused on the safety and effectiveness of etanercept in the long-term usage in JIA. My last observational study, on the minimal early response to treatment required to achieve remission in polyarticular JIA, has been awarded a best abstract prize at the Paediatric Rheumatology European Congress PRES 2020.
Outside my work, I enjoy learning new languages, and spending time with good friends and family.
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
Giulia Armaroli et al.
Arthritis Research & Therapy 2020 22:258
Published on: 22 September 2020